FilingPulse

RNAC insider transaction filings

Cartesian Therapeutics, Inc. — 28 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-04-06. Screen RNAC transaction legs live →

FiledFormInsiderReported transactionsSource
2026-04-064Hoge Elizabeth — 10% owner
Seven One Eight Three Four Irrevocable Trust — 10% owner		Option exercise (M): 758,001 · Option exercise (M): 22,740.03 (derivative)EDGAR
2026-04-064Kalayoglu Murat — 10% ownerOption exercise (M): 758,001 · Option exercise (M): 22,740.03 (derivative)EDGAR
2026-03-134Singer Michael — DirectorGift (G): 6,555 @ $0EDGAR
2026-01-084Brunn Carsten — President and CEO, DirectorSale (S): 23,766 @ $6.82EDGAR
2026-01-084Miljkovic Milos — Chief Medical OfficerSale (S): 3,573 @ $6.82EDGAR
2026-01-084Davis Blaine — Chief Financial OfficerSale (S): 10,591 @ $6.82EDGAR
2026-01-064DeSilva Nishan M — DirectorGrant/award (A): 2,600 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2026-01-064Brunn Carsten — President and CEO, DirectorGrant/award (A): 143,200 @ $0 · Grant/award (A): 415,700 (derivative) @ $0EDGAR
2026-01-064Malik Kemal — DirectorGrant/award (A): 2,600 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2026-01-064Miljkovic Milos — Chief Medical OfficerGrant/award (A): 27,000 @ $0 · Grant/award (A): 77,000 (derivative) @ $0EDGAR
2026-01-064Seymour June Ann — Chief Accounting OfficerGrant/award (A): 6,500 @ $0 · Grant/award (A): 19,000 (derivative) @ $0EDGAR
2026-01-064Davis Blaine — Chief Financial OfficerGrant/award (A): 37,000 @ $0 · Grant/award (A): 109,000 (derivative) @ $0EDGAR
2026-01-064English Emily — Chief Operations OfficerGrant/award (A): 24,000 @ $0 · Grant/award (A): 71,000 (derivative) @ $0EDGAR
2026-01-064Singer Michael — DirectorGrant/award (A): 2,600 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2026-01-064Kalayoglu Murat — Director, 10% ownerGrant/award (A): 2,600 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2026-01-064BARABE TIMOTHY C — DirectorGrant/award (A): 2,600 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2026-01-064ZENNER PATRICK J — DirectorGrant/award (A): 2,600 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2026-01-064SPRINGER TIMOTHY A — Director, 10% ownerGrant/award (A): 2,600 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2026-01-024English Emily — Chief Operations OfficerOption exercise (M): 7,500 @ $3.30 · Option exercise (M): 7,500 (derivative)EDGAR
2025-12-184Bot Adrian Ion — DirectorGrant/award (A): 5,800 @ $0 · Grant/award (A): 17,200 (derivative) @ $0EDGAR
2025-12-084BARABE TIMOTHY C — DirectorPurchase (P): 30,000 @ $6.86EDGAR
2025-12-024English Emily — Chief Operations OfficerOption exercise (M): 7,500 @ $3.30 · Option exercise (M): 7,500 (derivative)EDGAR
2025-11-194Singer Michael — DirectorGift (G): 20,000 @ $0EDGAR
2025-10-284Seymour June Ann — Chief Accounting OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-05-144English Emily — Chief Operations OfficerOption exercise (M): 7,500 @ $3.30 · Option exercise (M): 7,500 (derivative)EDGAR
2025-04-164English Emily — Chief Operations OfficerOption exercise (M): 7,500 @ $3.30 · Option exercise (M): 7,500 (derivative)EDGAR
2025-04-114SPRINGER TIMOTHY A — Director, 10% ownerPurchase (P): 7,342 @ $9.43 · Purchase (P): 31 @ $9.95 · Purchase (P): 41,604 @ $9.43 · Purchase (P): 178 @ $9.95 · Purchase (P): 7,966 @ $10.43 · Purchase (P): 609 @ $10.92 · +4 moreEDGAR
2025-03-204SPRINGER TIMOTHY A — Director, 10% ownerPurchase (P): 14,740 @ $14.42 · Purchase (P): 20,234 @ $14.97 · Purchase (P): 54,889 @ $15.59EDGAR

Recent 8-K events — Cartesian Therapeutics, Inc.

FiledFormItems reportedSource
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-178-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-06-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-268-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-04-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-01-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2025-12-188-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.05 — Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2025-11-138-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RNAC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →